PROGRAM / PROGRAMA
What's New in Skin Cancer 2015

09:00    Opening Ceremony
                Skin Cancer: The epidemic of 21st century?
                            Prof. João Maia Silva - Hospital CUF Descobertas, Lisboa, Portugal

             Farmacoeconomy
09:40    Do you want to hear the bad news? The healthcare expenditure of NMSC.
                            Prof. Doutor António Vaz Carneiro - CEMBE Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal

10:00    Evidence of cost-effectiveness and other barriers to patient access to new treatments for
                melanoma
                            Dr. Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy

10:20    Coffee break

             Non melanoma skin cancer
10:40    New approach for diagnosis of AK.
                            Prof. Iris Zalaudek - Medical University of Graz, Graz, Austria
11:00    The Hedgehog pathway as the underlying cause of basal cell carcinoma and clinical development
                in advanced BCC
                            Prof. Brigitte Dreno - CHU Nantes, Nantes, France

             Malignant melanoma
11:40    What is new in genetics of melanoma? How is it changing my clinical practice?
                            Prof. Susana Puig - Hospital Clinic, Barcelona, Spain
12:00    Melanoma susceptibility and longevity. What is the trade off?
                            Prof. Veronique Bataille - Hemel Hempstead Hospital, London, United Kingdom
12:20    Pros and cons of testing in melanoma follow-up
                           Dr. U. Leiter - University of Tuebigen, Tuebigen, Germany

13:00    Lunch

             Current landscape of adjuvant therapy of melanoma.
             New therapies for advanced melanoma.
14:30    Who should receive adjuvant therapy?
                            Prof. Claus Garbe - University of Tuebigen, Tuebigen, Germany
14:50    Individualized treatments for advanced melanoma. Already a reality?
                            Prof. Claus Garbe - University of Tuebigen, Tuebigen, Germany

            What is known about evidence-based medicine demonstrated through
            dermatology surgery topics?
15:20    Surgery of the primary malignant melanoma. Controversies about excision margins
                            Prof. Amod Sarnaik - H. Lee Moffitt Cancer Center, Tampa, USA
15:40    Sentinel lymph node biopsy as a surgical procedure. Outweighing risk and benefits in certain
                clinical settings
                            Prof. Alexander von Akkooy - Netherlands Cancer Institute, Amsterdam, The Netherlands
16:00    Surgery for distant metastatic malignant melanoma. Identifying candidates for surgery of the
                distant metastasis
                            Prof. Amod Sarnaik - H. Lee Moffitt Cancer Center, Tampa, USA


Download program / Programa para download
Rua General Silva Freire 157 H
1800 - 210 Lisboa
Tel: +351 214 164 710
skincancer@cast.pt
CAST